Robert Benjamin Stein Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Benjamin Stein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Benjamin Stein. Robert Benjamin Stein is a Director in Protagenic Therapeutics, Inc.\new ($ATRN) and a Chief Scientific Officer in AGENUS INC ($AGEN) and a President R&D in AGENUS INC ($AGEN) and a EVP, Research and Development in MIMEDX GROUP, INC. ($AYXC.OB).
Address: C/O AGENUS INC. 3 FORBES ROAD LEXINGTON 02421 MA
Companies in which Robert Benjamin Stein is an Insider
AGENUS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert Benjamin Stein: President R&D, Chief Scientific Officer
Holdings: 20,776 shares
Current Value: $82,896
Latest Transaction: Jun 16 2016
$AGEN Market Capitalization: $345.02M
$AGEN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MIMEDX GROUP, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Robert Benjamin Stein: EVP, Research and Development
Holdings: 191,068 shares
Latest Transaction: Mar 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protagenic Therapeutics, Inc.\new
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of Robert Benjamin Stein: Director
Holdings: 240,000 shares
Latest Transaction: Feb 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert Benjamin Stein
Sentiment: All, AGEN, AYXC.OB, PTIX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | AYXC.OB | MIMEDX GROUP, INC. | Stein Robert Benjamin | EVP, Research and D ... | Grant | A | 0.00 | 109,235 | 0 | 191,068 | 81.8 K to 191.1 K (+133.49 %) |
| Aug 12 2020 | AYXC.OB | MIMEDX GROUP, INC. | Stein Robert Benjamin | EVP, Research and D ... | Grant | A | 6.11 | 81,833 | 500,000 | 81,833 | 0 to 81.8 K |
| Feb 26 2020 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 150,000 | 262,500 | 150,000 | |
| Oct 18 2017 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
| Jun 21 2016 | ATRN | Protagenic Therape ... | Stein Robert Benjamin | Director | Grant | A | 1.25 | 40,000 | 50,000 | 240,000 | 200 K to 240 K (+20.00 %) |
| Jun 16 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | President R&D | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
| Jun 16 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | President R&D | Option Exercise | A | 4.16 | 250,000 | 1,040,000 | 250,000 |